Thomas, McNerney & Partners is a health care venture capital firm with
approximately $600 million under management focused on investing in life
science and medical technology companies.
The firm targets investments in the pharmaceutical, medical device,
biotechnology and diagnostic sectors, as well as in other areas that utilize
medical technology innovation. Companies raising growth capital for product
commercialization or developing therapeutic products for indications with
high unmet medical need are of particular interest.
Thomas, McNerney & Partners invests in companies at all stages of their
development. In addition to
providing growth capital to emerging companies to advance clinical
development or for product
commercialization, the partnership has significant experience spinning out
products and divisions from
major medical device and pharmaceutical companies, consolidating companies
through roll-up strategies, participating in structured financings for
public companies and leading recapitalizations. The firm also has
a strong track record of helping entrepreneurs launch companies with seed
and early stage funding.
The firm has a nationwide footprint, with offices on the East Coast, in the
Midwest and on the West Coast. Situated in three hotbeds of life science and
medical technology innovation, the Thomas, McNerney & Partners team has broad
geographical reach and the ability to provide portfolio companies with local
support as well as access to multiple networks.